Physician
Obstetrics & Gynecology
Dr. Walter K. Kinney, MD
|
|
Give Review
Walter Kinney is an expert in the field of Obstetrics & Gynecology. He studied medicine at Columbia University College of Physicians & Surgeons. Columbia University College of Physicians & Surgeons is a top medical college. Columbia University College of Physicians & Surgeons is ranked 8 in research and 52 in primary care medicine He received 3 awards: "Meaningful Use Stage 1 Certification", "Fellow (FACS)" and "Fellow (FACOG)". Walter Kinney is a published doctor as well. He has 66 publications published. The latest was: Missed opportunities for cervical cancer screening of HMO members developing invasive cervical cancer (ICC).
Publications
- A Common Clinical Dilemma: Management of Abnormal Vaginal Cytology and Human Papillomavirus Test Results.
- Use of Primary High-Risk Human Papillomavirus Testing for Cervical Cancer Screening: Interim Clinical Guidance.
- Increased Cervical cancer risk associated with screening at longer intervals.
- Interobserver reproducibility and accuracy of p16/Ki-67 dual-stain cytology in Cervical cancer screening.
- Reassurance against future risk of preCancer and Cancer conferred by a negative human papillomavirus test.
- The low risk of preCancer after a screening result of human papillomavirus-negative/atypical squamous cells of undetermined significance papanicolaou and implications ...
- State of the Science: Cervical cancer screening in transition.
- Cervical Excisional Treatment of Young Women: A Population-based Study.
- Cervical Cancer Rates After the Transition From Annual Pap to 3-Year HPV and Pap.
- Recommendations for a national agenda to substantially reduce Cervical cancer.
- Risk of Cervical precancer and cancer in women with Cervical intraepithelial neoplasia grade 1 on endoCervical curettage.
- Benchmarking CIN 3+ Risk as the Basis for Incorporating HPV and Pap Cotesting into Cervical Screening and Management Guidelines.
- Five-Year Risks of CIN 3+ and Cervical Cancer Among Women With HPV Testing of ASC-US Pap Results.
- Five-Year Risks of CIN 2+ and CIN 3+ Among Women With HPV-Positive and HPV-Negative LSIL Pap Results.
- Five-Year Risks of CIN 3+ and Cervical Cancer Among Women With HPV-Positive and HPV-Negative High-Grade Pap Results.
- Five-Year Risks of CIN 3+ and Cervical Cancer Among WomenWho Test Pap-Negative But Are HPV-Positive.
- Five-Year Risk of CIN 3+ to Guide the Management of Women Aged 21 to 24 Years.
- Follow-up Testing After Colposcopy: Five-Year Risk of CIN 2+ After a Colposcopic Diagnosis of CIN 1 or Less.
- Five-Year Risk of Recurrence After Treatment of CIN 2, CIN 3, or AIS: Performance of HPV and Pap Cotesting in Posttreatment Management.
- 2012 updated consensus guidelines for the management of abnormal Cervical cancer screening tests and cancer precursors.
- A study of borderline positive Hybrid Capture 2 tests in the Kaiser Permanente Northern California Cervical screening program: Evidence against retesting.
- Screening history preceding a diagnosis of Cervical cancer in women age 65 and older.
- Risk of occult inguinofemoral lymph node metastasis from squamous Carcinoma of the vulva.
- Whole abdomen radiotherapy for patients with peritoneal dissemination of endometrial adenoCarcinoma.
- The Value of Ultrasound Monitoring of Adnexal Masses for Early Detection of Ovarian Cancer.
- Chemoradiation for primary invasive squamous Carcinoma of the vagina.
- Synchronous radiation and cytotoxic chemotherapy for locally advanced or recurrent squamous Cancer of the vulva.
- Flow-cytometric DNA analysis of stages IB and IIA cervical Carcinoma.
- Long-term survival and sequelae after surgical management of invasive cervical Carcinoma diagnosed at the time of simple hysterectomy.
- Value of adjuvant whole-pelvis irradiation after Wertheim hysterectomy for early-stage squamous Carcinoma of the cervix with pelvic nodal metastasis: a matched-control...
- Identification of prognostic factors and risk groups in patients found to have nodal metastasis at the time of radical hysterectomy for early-stage squamous Carcinoma ...
- Wertheim hysterectomy in the geriatric population.
- Identification of a low-risk subset of patients with stage IB invasive squamous Cancer of the cervix possibly suited to less radical surgical treatment.
- Surgical treatment of patients with stages IB and IIA Carcinoma of the cervix and palpably positive pelvic lymph nodes.
- Condylomata acuminata. Roles of different techniques of laser vaporization.
- Second-look operation in ovarian Cancer.
- Treatment of recurrent adenoCarcinoma of the endometrium with pelvic exenteration.
- Prophylactic chemoradiation of inguinofemoral lymph nodes in patients with locally extensive vulvar Cancer.
- Where's the high-grade Cervical neoplasia? The importance of minimally abnormal Papanicolaou diagnoses.
- Identifying women with Cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results.
- Atypical glandular cells of undetermined significance (AGUS): cytopathologic features, histopathologic results, and human papillomavirus DNA detection.
- Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and Cervical cytology: a population-based study in routine clinical practice.
- Characteristics of 44 Cervical cancers diagnosed following Pap-negative, high risk HPV-positive screening in routine clinical practice.
- Five-year experience of human papillomavirus DNA and Papanicolaou test cotesting.
- Relationship of atypical glandular cell cytology, age, and human papillomavirus detection to Cervical and endometrial cancer risks.
- The age-specific relationships of abnormal cytology and human papillomavirus DNA results to the risk of Cervical precancer and cancer.
- Screening interval and risk of invasive squamous cell Cervical cancer.
- Papanicolaou smear history and diagnosis of invasive cervical Carcinoma among members of a large prepaid health plan.
- Lessons from practice: risk of CIN 3 or Cancer associated with an LSIL or HPV-positive ASC-US screening result in women aged 21 to 24.
- Age-appropriate use of human papillomavirus vaccines in the U.S.
- Human papillomavirus testing in the prevention of Cervical cancer.
- Variable risk of Cervical precancer and cancer after a human papillomavirus-positive test.
- Human papillomavirus (HPV) genotypes in women with Cervical precancer and cancer at Kaiser Permanente Northern California.
- Risk of Cervical precancer and cancer in women aged 30 years and older with an HPV-negative low-grade squamous intraepithelial lesion screening result.
- Stage at diagnosis and mortality in patients with adenoCarcinoma and adenosquamous Carcinoma of the uterine cervix diagnosed as a consequence of cytologic screening.
- Cervical cancer after multiple negative cytologic tests in long-term members of a prepaid health plan.
- Positive peritoneal cytology in stage I Carcinoma of the cervix.
- Comparison of the cobas Human Papillomavirus (HPV) test with the hybrid capture 2 and linear array HPV DNA tests.
- Advancing age and Cervical cancer screening and prognosis.
- The integration of computed tomography and magnetic resonance imaging in treatment planning for gynecologic Cancer.
- Missed opportunities for Cervical cancer screening of HMO members developing invasive Cervical cancer (ICC).
- Special commentary: patient safety and the next generation of HPV DNA tests.
- American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent Cervical cancer and its precursors.
- On maintaining the balance.
- Cervical cancer control, priorities and new directions.
Schools
Columbia University College Of Physicians and Surgeons
Mayo Grad School MedMayo Fndn
Procedures Preformed
- Colposcopy
- Destruction or Excision of Vaginal Lesions
- EndoCervical Curettage
- Hysterectomy - Laparoscopic
- View All
Conditions Treated
- Carcinoma in Situ
- Cervical Cancer
- Cervicitis
- Endometriosis
- View All
Doctors Specialties
- Gynecologic Oncology
- Obstetrics
- Gynecology
Accepted Insurances
Awards
- Meaningful Use Stage 1 Certification
- Fellow (FACS)
- Fellow (FACOG)
Education
-
Mayo School of Graduate Medical Education -
Columbia University College of Physicians & Surgeons
Helpful Reviews
Similar Doctors
|
|
Dr. Rebecca L. King, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Stephen G. Hiuga, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Michael W. Chu, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Ernest J. Zeringue, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gary S. Leiserowitz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lloyd H. Smith, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edwin A. Alvarez, MD |
|
Dr. Wiley L. Fowler, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Douglas L. Gillott, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jo L. Taylor, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeffrey S. Skilling, MD |
|
|
Dr. Vikas Mahavni, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alexander Locke III, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Jennifer Ozeir, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Susan J. Diez, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Colleen M. Hendershott, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Danielle M. Manning, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kristen Wolfe, MD
This Doctor is OpenDoctor Recommended.
|